Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials
Journal
BMJ open
Journal Volume
12
Journal Issue
10
Date Issued
2022-10-14
Author(s)
Tsai, Wan-Chuan
Hsu, Shih-Ping
Chiu, Yen-Ling
Yang, Ju-Yeh
Pai, Mei-Fen
Ko, Mei-Ju
Peng, Yu-Sen
Wu, Hon-Yen
Abstract
To assess the cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients without diabetes.
Subjects
cardiology; chronic renal failure; diabetic nephropathy & vascular disease; heart failure; nephrology
SDGs
Publisher
BMJ PUBLISHING GROUP
Type
journal article